论文部分内容阅读
目的探讨时间节点管理提高急性缺血性脑卒中患者溶栓效果中的作用。方法将2015年9月至2016年11月在我院脑血管病中心接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗的162例急性缺血性脑卒患者,按溶栓后24h NIHSS评分分为有效组及无效组,比较有效组及无效组间从发病至进针的各段时间的差异,评价时间管理对预后的影响。结果在时间管理上,有效组与无效组患者,发病至溶栓开始的时间差异有统计学意义(P<0.05),且主要是由发病至就诊时间的差异(P<0.05)导致的。结论在急性缺血性脑卒中患者rt-PA静脉溶栓治疗中,发病至溶栓开始的时间短则溶栓疗效良好,降低患者发病至就诊的时间可提高静脉溶栓的疗效。
Objective To explore the role of time management in improving thrombolytic activity in patients with acute ischemic stroke. Methods A total of 162 acute ischemic stroke patients treated by intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in our hospital from September 2015 to November 2016 were treated with The NIHSS score at 24h after the embolization was divided into effective group and ineffective group, and the differences between the effective group and the ineffective group from the onset to the injection were compared to evaluate the impact of time management on the prognosis. Results In time management, the time from onset to thrombolysis was statistically significant (P <0.05), and was mainly due to the difference between onset and treatment time (P <0.05). Conclusions In patients with acute ischemic stroke, intravenous thrombolysis is an effective thrombolytic therapy with a short onset of thrombolysis and a reduction in the time from onset to treatment of patients with intravenous thrombolysis.